A
Phase III Research Study for Macular Disease (AMD):Information for Potential Participants Protocol Number C-02-27
Alcon Research, Ltd. is currently conducting a
research study in the United Kingdom and other countries. The study aims at
evaluating an experimental medicine for the "wet" form of age-related
macular degeneration (AMD). General information about AMD is presented here, as
well as information about participating in this clinical trial.
For
more information about participating in this clinical trial, please complete the ONLINE
ENQUIRY FORM.
We
will contact your General Practitioner to find out whether the research study
could apply to you.
Alcon makes no
representations or warranties as to the safety or the effectiveness of this
experimental treatment for AMD which you will read about on this web site.
Alcon's research study for this treatment must be completed to confirm the
safety and efficacy of this experimental treatment and go through Product
License approval before it is commercially available.
